Adaptive Biotechnologies Corp (ADPT)
2.57
+0.06
(+2.39%)
USD |
NASDAQ |
Apr 23, 16:00
2.57
0.00 (0.00%)
After-Hours: 20:00
Adaptive Biotechnologies Market Cap: 372.89M for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 364.18M |
| April 19, 2024 | 348.22M |
| April 18, 2024 | 338.79M |
| April 17, 2024 | 354.03M |
| April 16, 2024 | 399.00M |
| April 15, 2024 | 422.22M |
| April 12, 2024 | 436.73M |
| April 11, 2024 | 380.14M |
| April 10, 2024 | 387.40M |
| April 09, 2024 | 425.12M |
| April 08, 2024 | 410.61M |
| April 05, 2024 | 374.34M |
| April 04, 2024 | 396.10M |
| April 03, 2024 | 388.85M |
| April 02, 2024 | 432.38M |
| April 01, 2024 | 451.24M |
| March 28, 2024 | 465.75M |
| March 27, 2024 | 419.32M |
| March 26, 2024 | 417.87M |
| March 25, 2024 | 452.69M |
| March 22, 2024 | 470.10M |
| March 21, 2024 | 483.16M |
| March 20, 2024 | 490.41M |
| March 19, 2024 | 474.45M |
| March 18, 2024 | 461.39M |
| Date | Value |
|---|---|
| March 15, 2024 | 470.10M |
| March 14, 2024 | 473.00M |
| March 13, 2024 | 494.76M |
| March 12, 2024 | 520.88M |
| March 11, 2024 | 548.45M |
| March 08, 2024 | 529.59M |
| March 07, 2024 | 500.57M |
| March 06, 2024 | 523.78M |
| March 05, 2024 | 548.45M |
| March 04, 2024 | 578.92M |
| March 01, 2024 | 584.72M |
| February 29, 2024 | 596.33M |
| February 28, 2024 | 602.13M |
| February 27, 2024 | 619.54M |
| February 26, 2024 | 603.58M |
| February 23, 2024 | 586.17M |
| February 22, 2024 | 562.92M |
| February 21, 2024 | 554.21M |
| February 20, 2024 | 558.57M |
| February 16, 2024 | 558.57M |
| February 15, 2024 | 574.53M |
| February 14, 2024 | 571.62M |
| February 13, 2024 | 525.20M |
| February 12, 2024 | 568.72M |
| February 09, 2024 | 548.41M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
338.79M
Minimum
Apr 18 2024
9.324B
Maximum
Jan 22 2021
3.250B
Average
3.342B
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 2.287M |
| Palatin Technologies Inc | 28.08M |
| iBio Inc | 6.655M |
| Theriva Biologics Inc | 6.420M |
| Oragenics Inc | 4.839M |
Market Cap Related Metrics
| PS Ratio | 2.179 |
| PEG Ratio | -0.1548 |
| Price to Book Value | 1.209 |
| Price | 2.57 |
| Earnings Yield | -60.70% |
| PEGY Ratio | -0.1548 |